Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in

Leike Xie1, Chi Vo-Ransdell, Britain Abel

  • 1Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA.

Insights

Caveolin-2 (Cav-2) negatively regulates the anti-proliferative effects of transforming growth factor-beta (TGF-β) in endothelial cells. Loss of Cav-2 enhances TGF-β signaling, while its reexpression diminishes this response.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-β) is a key regulator of cell proliferation and signaling.
  • Caveolins, including caveolin-2 (Cav-2), are proteins involved in cellular signaling and membrane dynamics.
  • The precise role of Cav-2 in TGF-β signaling pathways, particularly in endothelial cells, requires further elucidation.

Purpose of the Study:

  • To investigate the role of caveolin-2 (Cav-2) in regulating the anti-proliferative function of transforming growth factor-beta (TGF-β) in endothelial cells (ECs).
  • To elucidate the molecular mechanisms by which Cav-2 influences TGF-β signaling.
  • To determine if Cav-2 affects the localization of TGF-β pathway components.

Main Methods:

  • Utilized wild-type (WT) and Cav-2 knockout endothelial cells (ECs).
  • Employed retroviral reexpression of Cav-2 in knockout ECs.
  • Assessed cell proliferation using MTT assays, cell counting, and bromodeoxyuridine incorporation.
  • Analyzed TGF-β signaling components, including p27, retinoblastoma protein, Alk5, and Smad2/3 phosphorylation.
  • Investigated protein localization in lipid raft/caveolar microdomains via sucrose fractionation gradients.

Main Results:

  • Cav-2 knockout ECs exhibited profoundly inhibited proliferation upon TGF-β treatment compared to WT ECs.
  • Reexpression of Cav-2 in knockout ECs restored the modest anti-proliferative effect of TGF-β.
  • Cav-2 suppressed TGF-β-induced upregulation of p27 and hyperphosphorylated retinoblastoma protein.
  • Cav-2 inhibited the Alk5-Smad2/3 pathway, reducing Smad2/3 phosphorylation and target gene activation.
  • Cav-2 expression did not significantly alter the targeting of TGF-β receptors or Smad2/3 to caveolae/lipid rafts.

Conclusions:

  • Caveolin-2 plays a negative regulatory role in the anti-proliferative function and signaling of TGF-β in endothelial cells.
  • Cav-2 inhibits TGF-β's anti-proliferative action by suppressing the Alk5-Smad2/3 pathway.
  • This regulation by Cav-2 is independent of Cav-1 expression and does not involve altered localization of key signaling molecules to lipid rafts.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...